GSO4SCHOOL Summer School 2020
Several ground-breaking scientific findings regarding the early diagnosis of Parkinson’s disease are expected to be announced during GeNeDis 2014, the 1st World Congress on Geriatrics and Neurodegenerative Disease Research, which will take place in Corfu, Greece, on 10-13 April 2014.
For the first time in Greece, GeNeDis 2014 (Geriatrics and Neurodegenerative Disease) brings together these scientific fields and focuses on recent advances in geriatrics and neurodegeneration, ranging from basic science to clinical and pharmaceutical developments and will provide an international forum for the latest scientific discoveries, medical practices and care initiatives.
Leading scientists and experts, students, physicians and nurses, professionals and many other participants will discuss the latest major challenges, new drug targets, the development of new biomarkers, imaging techniques, novel protocols for early diagnosis of neurogenerative diseases and several other scientific achievements.
Among the scientists who will be present at GeNeDis 2014 are: Prof. Nikolaos Robakis (Robakis Laboratory of Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York), Prof. George Paxinos (Prince of Wales Medical Research Institute and The University of New South Wales, Sydney, Australia), Prof. Benjamin Wolozin (Alzheimer’s Disease Center, Boston University), Prof. Arno Villringer (Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig), Prof. Panteleimon Giannakopoulos (Faculté de médecine, Université de Genève), Prof. Vasilis Ntziachristos (Institute for biological and medical imagingm Technische Universität München), Prof. Constantin Bouras (University of Geneva), and others.
The scientific team at the Department of Informatics of Ionian University, Greece is expected to announce the first steps of the investigation for the early diagnosis of Parkinson’s disease . The researchers at the Ionian University about three years ago had presented for the first time the mechanics of the birth of Alzheimer’s diseases, bringing high hopes for the suspension of disease.
The research group of Associate Professor and President of the Department of Informatics at Ionian University, Panagiotis Vlamos, will present during GeNeDis 2014 the operating mechanism of Parkinson’s disease, based on which the biomarkers that cause the disease will be defined, and a protocol of early diagnosis of the disease will be created.
According to Prof. Vlamos, the research process of creating a protocol for the early diagnosis of the Parkinson’s disease is expected to last about three years, following the same procedure as early diagnosis for Alzheimer’s (started in 2011), which today is already in the second phase of clinical trials. In this phase the clinical data of 1,000 cases are collected and will be overseen by an international auditing board.
Furthermore, during the conference the launch of the -unique in Europe- Bioinformatics and Human Electrophysiology Laboratory in the Department of Informatics, Ionian University, is going to be officially announced. The Laboratory is funded by the Region of Ionian Islands with 2.4 million euros. The Laboratory will gather clinical data of all neurodegenerative diseases which will be processed for further investigations .
GeNeDis 2014 proceedings will be published by Springer in the Series: Advances in Experimental Medicine and Biology (AEMB), 2012- Impact Factor: 1.825.
The conference will be held under the auspices of the Greek Ministry of Health and is supported by the European Commission and the Commissioner for Research and Innovation Máire Geoghegan-Quinn who is going to address the conference.
GeNeDis 2014 is organised by the Ionian University and Science View and co-organised by the Hellenic Open University, Greece, University of Salento, Italy, and Region of Ionian Islands, Greece.
And is supported by many medical associations and societies.
You can download the Conference Program from here.
For more information you can contact Mr. Menelaos Sotiriou at +30 210 9231955, info@scienceview.gr and info@genedis.eu
Related posts
